Smith & Nephew plc vs United States Oil ETF — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while United States Oil ETF trades at $130.25. The key difference: Smith & Nephew plc pays a 2.57% dividend while United States Oil ETF pays none, and United States Oil ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| SNN | USO | |
|---|---|---|
Market Cap | $12.64B | — |
Sector | Health | — |
52-Week High | $38.70 | $152.96 |
52-Week Low | $28.73 | $66.17 |
Enterprise Value | $15.41B | — |
Dividend Yield | 2.57% | — |
Signals from Pluang's Aura AI — not financial advice
SNN trades at $30.21, down 1.24% today, with a bearish technical signal and mixed earnings history. Revenue grew to $5.81B in 2024 with net income of $412M, while valuation ratios like P/E of 21.25 and P/S of 2.15 suggest moderate pricing. Recent news highlights product launches in robotics and wound care, supporting growth initiatives.
Outlook is cautiously optimistic with strong cash flow and analyst buy ratings at 27%, but risks include earnings misses and rising debt. The stock offers potential from operational improvements, though investor sentiment remains divided amid competitive pressures.
USO trades at $125.51, up 1.25% with a bullish technical signal driven by moving averages. Recent news highlights Middle East supply disruptions as a key catalyst, with oil prices testing resistance levels. The stock shows strong momentum but overbought RSI readings suggest caution near-term.
Outlook remains positive given geopolitical tensions supporting oil prices, though elevated RSI indicates potential pullback risk. Key support sits at $124, with resistance at $127. Investors face volatility from supply shocks and inflation concerns, requiring careful position management.
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →